Inparticular, numerous studies have demonstrated the upregulated expression of IGF2 innonalcoholic fatty liver disease (NAFLD) (Chiappiniet al., 2006; Tybl et al., 2011;Kessler et al., 2016). The gene discussed is IGF2; the disease is metabolic dysfunction-associated steatotic liver disease.